Legal Issues
Releases published in the last 30 days. 
Page 1 of 2
- FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation
- 1/12/2026 3:15:25 PM
- The U.S. Food and Drug Administration announced it is sharing information about the agency’s flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene therapies (CGT).
- Airbus Helicopters proactively releases an EASB in response to H160 ditching in Brazil
- 1/9/2026 3:00:23 PM
- Airbus Helicopters was informed of an event that occurred on a H160 operated in Brazil on January 2nd 2026. During a cruise flight, the pilots felt significant vibrations and decided to ditch.
- Caribbean Legal Sector Accelerates AI Adoption as Trust Becomes the Differentiator
- 1/9/2026 12:39:16 PM
- LexisNexis® Legal & Professional, a global leader in private, secure, authoritative, legal AI workflow solutions, has published a new survey showing rapid AI uptake among Caribbean attorneys, with three-quarters saying trusted legal sources are key to confident AI use.
- Legal Industry Experiencing Tectonic Shift: Technology, Talent and Demand Prompting Law Firms to Evolve
- 1/9/2026 12:28:23 PM
- • 2026 Report on the State of the US Legal Market notes industry experiencing unprecedented demand growth; profits per lawyer of Am Law 100 firms have soared 53.7% since 2019 • Technology investment up nearly 10% as law firms race to integrate AI; lawyer compensation rose more than 8% Thomson Reuters (TSX/NYSE: TRI), a global content and technology company, and …
- Thomson Reuters Fourth-Quarter and Full-Year 2025 Earnings Announcement and Webcast Scheduled for February 5, 2026
- 1/7/2026 12:08:33 PM
- Thomson Reuters (TSX/Nasdaq: TRI) announced today its fourth-quarter and full-year 2025 earnings will be issued via news release on Thursday, February 5, 2026.
- Secretary Rollins Announces New Priorities for Research and Development in 2026
- 12/30/2025 7:32:58 PM
- Today, U.S. Secretary of Agriculture Brooke L. Rollins, signed a Secretary’s Memorandum (PDF, 909 KB) that puts forth a focused effort to establish new priorities for future research and development activities funded by the U.S.
- Citi Statement on AO Citibank Sale Approvals
- 12/29/2025 9:20:43 PM
- Citi confirmed today that it has obtained the internal approvals required to proceed with the planned sale of AO Citibank, which conducts Citi’s remaining operations in Russia, to Renaissance Capital (RenCap).
- FDA Finds Insufficient Data to Determine Safety of PFAS in Cosmetic Products
- 12/29/2025 9:15:01 PM
- The U.S. Food and Drug Administration today released a congressionally mandated report under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) evaluating the use of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in cosmetic products.
- Clariant rejects allegations from MOL Group and Braskem against four companies related to the 2020 competition law infringement
- 12/23/2025 10:14:04 AM
- AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Clariant, a sustainability-focused specialty chemical company, today announced that the company received two claims for damages against four companies, including Clariant, from MOL Petrolkémia Zrt.
- Mitratech Launches Next Phase of ARIES™ AI for Legal Professionals
- 12/20/2025 12:13:52 AM
- Mitratech, a leading global provider of legal, risk, and human resources software, announces the international expansion of ARIES™ Non-LEDES Invoice Capture for eBilling customers, marking an exciting next step in a series of forthcoming Intelligent Document Processing (IDP) advancements across the Company’s governance-grade AI ecosystem.
- A Tale of Justice, Family, and Betrayal Unfolds in Walter Signorelli’s Riveting Crime Novel, “The Detective’s Sons”
- 12/19/2025 9:26:51 PM
- In his masterfully written crime novel “The Detective’s Sons,” author Walter Signorelli delivers a powerful story of love, deception, and the harrowing choices that test the limits of justice.
- Sinclair Issues Statement on Merger Proposal with The E.W. Scripps Company
- 12/18/2025 8:49:01 PM
- Sinclair, Inc. (Nasdaq: SBGI) (the “Company” or “Sinclair”) made the following statement in response to The E.W. Scripps Company’s (Nasdaq: SSP) (“Scripps”) rejection of the Company’s proposal for a potential combination with Scripps: “We are disappointed that despite Scripps encouraging Sinclair to make a proposal, Scripps’ board rejected the proposal without engaging.
- Bipartisan House Majority Opposes Performance Tax on Local Radio
- 12/18/2025 1:26:55 PM
- A bipartisan majority of the U.S. House of Representatives - 219 members - have signed on to the Local Radio Freedom Act (LRFA), a resolution opposing any new performance fee, tax, royalty or other charge on local broadcast radio stations.
- Euronext accelerates European CSD expansion, driving choice, efficiency and innovation in European capital markets
- 12/18/2025 1:25:15 PM
- Euronext, the leading European capital market infrastructure, today announced continued progress in its initiative to create a European central securities depository (CSD) model.
- Apple announces changes to iOS in Japan
- 12/17/2025 11:47:32 PM
- Apple today announced changes impacting iOS apps in Japan to comply with the Mobile Software Competition Act (MSCA). These updates create new options for developers to distribute apps on alternative app marketplaces and to process app payments for digital goods and services outside of Apple In-App Purchase.
- NAB Urges Action on Outdated Broadcast Ownership Rules Following FCC Oversight Hearing
- 12/17/2025 10:46:46 PM
- Following today’s Senate Commerce Committee oversight hearing with Federal Communications Commission Chairman Brendan Carr, President and CEO of the National Association of Broadcasters, Curtis LeGeyt, issued the following statement: “Today’s hearing underscored what local broadcasters have been saying for years: the rules governing television and radio ownership are badly …
- PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
- 12/17/2025 10:38:25 PM
- • PADCEV plus Keytruda is the first and only regimen without platinum-based chemotherapy to improve event-free and overall survival when used before and after surgery in cisplatin-eligible patients with muscle-invasive bladder cancer • Positive EV-304 data, combined with the recent unprecedented results from the EV-303 trial, highlight the potential of this …
- Gartner Survey Reveals Only 20% of Legal Matters Sent to Outside Counsel Stay Within Budget Range
- 12/17/2025 12:08:35 PM
- In-house lawyers report that total cost of matters sent to outside counsel fall within the planned budget scope only one-fifth of the time, according to Gartner, Inc., a business and technology insights company.
- Lex Machina and CounselLink+ Win 2025 LegalTech Breakthrough Awards
- 12/17/2025 12:02:33 AM
- Lex Machina® and CounselLink+™ have been named winners in the 2025 LegalTech Breakthrough Awards, which recognize the top companies, technologies, and products driving innovation across the legal technology industry.
- Euronext strengthens European fixed-income markets with streamlined government bond settlement
- 12/16/2025 10:46:30 PM
- Euronext announced that Euronext Securities Milan has asked LCH SA for the opening of settlement of all European government debts currently cleared by the CCP.